Conference - Events
Featured Events
Following the watershed approval of Iovance’s Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! As the only meeting placing the entire spotlight on TIL drug development, this summit will unveil the latest to share clinical updates, next-generation candidates, manufacturing innovations, and assay characterizations to turbocharge development of the next wave of TIL therapies. Hear from TIL industry leaders like Iovance, MD Anderson Cancer Center, Obsidian Therapeutics, Steven Rosenberg’s group from the National Institute of H…
The Medical Affairs Summit, scheduled for 24 - 25 October at the prestigious Encore Boston Harbor, in Boston, MA, is an exclusive, invitation-only summit that will bring together Clinical Trial Executives Representing Americas Pharmaceutical Industries and Innovative Pharmaceutical Companies from Across North America.
The summit’s content is aligned with key medical affairs challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
This year’s speaker lineup includes:
Victoria Samonte, M.D., Director, Medical Affairs, Abbott
Giovanni Passiatore, Head North America Medical Affairs, Chiesi Global Rare Diseases
Donnie Wooten, Head, Global Field Medical Excellence & Omnichannel Engagements, Organon & Co.
M…
The Ultimate Chance to Tackle Regulatory Challenges in the Cell and Gene Therapy Space!
With over 5,000 cell and gene therapies in pre-clinical and clinical development worldwide, regulatory clarity is crucial for developers striving for efficient and seamless approvals in their first regulatory submissions. Leading innovators are pioneering new approaches, like in vivo gene editing, rapidly pushing products from the clinic to commercialization. This rapidly evolving field is now on a mission to learn from case studies and glean insights from the forefront to optimize regulatory processes from pre-IND to approval.
Introducing the inaugural Cell and Gene Therapy Regulatory Affairs Summit in Washington D.C. This event will unite biopharma experts across non-clinical,clinical, and CMC regulat…
Events
The learning objectives of this conference include identifying advanced approaches toward hemophilia and diagnosing hemophilia and other inherited bleeding disorders. Participants will discuss the management of hemophilia and inherited bleeding disorders and receive updates on current research in these areas. The conference aims to offer in-depth exposure to multidisciplinary management strategies, improving the care of patients with hemophilia and inherited bleeding disorders. Additionally, it seeks to address unmet needs in hemophilia, ensuring comprehensive and cutting-edge knowledge dissemination for better patient outcomes.
Date and Time: Saturday, 05 October 2024 at 08:00 to Sunday, 06 October 2024 at 18:00
Increasingly, companies across Europe are recognizing the value of implementing Early Access Programmes to provide patients with access to life-changing medicines. However, challenges remain in adhering to a variety of cross-border regulations, clarifying rules around real-world data collection, and accurately anticipating supply volumes. To overcome these hurdles, it is essential for the industry to collaborate and share solutions.
Welcome to the 3rd Operationalise Early Access Programmes Summit Europe, dedicated to fostering open dialogue and sharing experiences in navigating the complex regulatory and operational landscape of Early Access Programmes. This October, join a community of over 140 experts in Access, Clinical Operations, Medical Affairs, and Clinical Supply from leading compa…
We extend a warm welcome to the Global Conference on Biosensors, where we will delve into the latest trends, applications, challenges, and advancements in the field. Our primary goal is to unite educators, experts, professionals, and research-oriented individuals in the biosensor sector to share profound knowledge for a brighter future through comprehensive discussions and presentations on key biosensor topics. We are thrilled to invite experts from across the globe to share their research insights, technological advancements, and perspectives on the most recent biosensor breakthroughs. This event offers a valuable opportunity for all attendees to gain essential knowledge about this rapidly evolving industry and explore the latest technologies and trends that are propelling growth and inno…
The focus is to delve into preventive measures and therapeutic strategies that can detect and prevent the progression of these conditions. The conference will feature sessions by distinguished leaders from various disciplines, including vascular surgery, radiology, medicine, podiatry, neurology, cardiology, and critical care. This will present a holistic view of patient management, encompassing both traditional practices and innovative treatments. Topics will cover the spectrum of vascular disease, such as peripheral arterial disease, aortic pathology,venous disease, diabetic foot complications, renal access surgery, cerebrovascular disease, and beyond. Interactive discussions, debates, and panel insights are designed to deepen our collective understanding and educational pursuit in vascul…
Welcome to The Pharmacy Show - The Largest Gathering of Community and Primary Care Pharmacy Professionals.
As the UK's leading trade show and educational conference for the pharmacy sector, The Pharmacy Show empowers you with cutting-edge knowledge, innovative solutions, and networking opportunities. Whether you're a community pharmacist or a healthcare professional in primary care, this event is your gateway to staying at the forefront of pharmaceutical advancements.
What can you expect?
- Attend over 150 educational sessions presented by more than 200 expert speakers across 9 theatres-these can be used for both planned and unplanned learning for revalidation.- Meet with over 300 exhibitors showcasing new products, solutions, and services to help you as a pharmacy professional and benefit…
SAE Media Group presents the 5th Annual Wearable Injectors and Connected Devices Conference on October 14th-15th, 2024, in London, UK.
Explore on-body device design, connectivity, and digital health applications with industry insights from big pharma. Discover key developments in wearable injectors, including demand for on-body devices and digitalized health for at-home self-administration of time-dependent, high-volume drugs.
Engage with regulatory updates, user-experience considerations, and patient-centric device development. Network over two days, with 75% of speakers from big pharma, and gain insights into wearable injector technologies, regulatory processes, and connectivity implementation.
Join pharma, biotech, and device developers to discuss trends, challenges, and strategies. Lea…
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.
The TGF-B Targeted Drug Development Summit returns to San Francisco for the 4th year to deep dive into the hottest topics in the field, such as combination strategies being employed by Genentech and discovering new and predictive biomarkers from Corbus Pharmaceuticals. This meeting will support you in securing clinical success with safe and efficacious TGF-B targeted therapies.
With a program consisting of TGF-B industry leaders such as Cue Biopharma, Synthis, and Pfizer, this year promises to spotlight innovative ways biotech and large pharma companies…
Are you listening to your patient community? It's not enough. Standing in the shadows and harvesting anecdotal insights won't build connections, create first-hand knowledge or illuminate your impact to internal stakeholders.
We must step forward and be visible, actively engaging in patient communities and embedding the patient voice internally. YOU are the patient advocate in your company, so overturn tokenistic gestures into meaningful actions that prioritize patients over patents.
This starts now. You must integrate and co-create from the outset, from clinical design to commercial execution to boost adherence, trial participation and create exceptional outcomes. Show that pharma is driven by more than profit - to build a world that empowers all patients and leaves no one in the dark. THI…
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.
Registration Link: https://pharma-partnering-summit.com/registration.html
Artificial Intelligence (AI) is leading technological advancements in the pharmaceutical sector, poised to transform pre-clinical drug discovery by reducing costs by up to 40% and creating a market valued at up to $50 billion in the next decade. This transformative period is upon us, and the AI in Drug Discovery conference offers a unique opportunity to hear directly from experts and gain strategies to enhance your operations.
Scheduled for October 2024 in the United States, the AI in Drug Discovery Conference comes after a successful event in March 2024 in the UK. Since then, the industry has achieved a groundbreaking milestone: the first wholly AI-discovered and designed drug is now in Phase 2 clinical trials.
The conference is driven by the industry's shift towards personalized therapie…
This conference promises to be an exceptional gathering of brilliant minds, dedicated professionals, and esteemed experts in the field of pathology and laboratory medicine. Our goal is to create an inspiring platform where knowledge, innovation, and collaboration converge.
URLs:Tickets: https://go.evvnt.com/2603422-0?pid=185Website: https://go.evvnt.com/2603422-2?pid=185
Prices:Doctors: AED 500.00,Medical Students: AED 250.00
Category: Exhibitions | Science, Health and Medicine | Medical and Pharmaceutical
Date and Time: 22nd October 2024 at 8:00 am to 23rd October 2024 at 5:00 pm
Venue details: Address Sky View, Emaar Square Area, Downtown Dubai, Dubai, 111969, United Arab Emirates
22-Oct-2024 - 23-Oct-2024
The BioPharma Clinical Trials Nexus is an esteemed conference reserved for invited attendees, bringing together influential clinical trial decision makers and innovative suppliers and solution providers. Our agenda is meticulously crafted to tackle key challenges in clinical trials, explore emerging market trends, and highlight effective strategies deployed by industry leaders. This event serves as a prime opportunity for clinical trials service providers to engage in fruitful business development initiatives.
Key Notes:
Tackling Clinical Development Expenses & Obstacles: Insights from a Small Biopharma Viewpoint
Exploring New Perspectives in Modern Clinical Research
Empowering Clinical Operations Professionals: Harnessing AI to Enhance Outcomes
Unleashing the Vital Potential of Co…
Welcome to the 3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the clinical trial industry. Join us on 22nd - 23rd Oct in beautiful New Jersey as we bring together top-notch clinical leaders for two days of insightful discussions and innovative solutions. Our summit will dive into four key streams: Site Staffing and Retention, Patient Recruitment & Enrollment, Feasibility and Study Start-Up, and Clinical Trial Forecasting, Budgeting, and Partnerships. Get ready to connect, learn, and exchange ideas as we explore the cutting-edge strategies that optimize site performance and drive successful clinical trial.
Conference Topic:
Training and development strategies to ensure highly skilled and competent site workforce
▪ Enhancing Diver…
Deliver a first-class customer journey.
It's getting harder to engage our customers.
More data is not translating into better customer interaction. Investments in tools and tech are not increasing face time. Every marketing, commercial and medical leader is striving to create the perfect, personalized customer journey, but one wrong step can lead to a 404 error message - your customer can no longer be found.
To regain our customers' time and trust, we must get better at predicting their unmet needs, their engagement preferences and their expectations of us, before they even know them themselves. We must pledge to provide consistent value first and foremost, through a data-backed, AI-powered, and customer-motivated engagement model. The future isn't that far away.
Join 350+ marketing, comme…
Following the watershed approval of Iovance’s Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! As the only meeting placing the entire spotlight on TIL drug development, this summit will unveil the latest to share clinical updates, next-generation candidates, manufacturing innovations, and assay characterizations to turbocharge development of the next wave of TIL therapies. Hear from TIL industry leaders like Iovance, MD Anderson Cancer Center, Obsidian Therapeutics, Steven Rosenberg’s group from the National Institute of H…
Join us for SAE Media Group's 2nd Annual RNA Therapeutics USA Conference on October 23-24, 2024, at Courtyard by Marriott Boston Downtown.
RNA therapies are at the forefront of genetic medicine, with the market projected to reach $1.81 billion by 2025. Explore mRNA vaccine advancements and regulatory successes shaping the field.
Discover the latest challenges and advancements in RNA delivery, particularly targeting the Central Nervous System. Uncover how RNA technologies are revolutionizing immunotherapies and vaccines, offering new hope for previously untreatable diseases.
Network with global experts from pharma and biotech, including Directors of RNA therapies, CEOs, scientists, and medical officers. Don't miss this opportunity to drive innovation in RNA therapeutics!
URLs:Tickets: …
The Medical Affairs Summit, scheduled for 24 - 25 October at the prestigious Encore Boston Harbor, in Boston, MA, is an exclusive, invitation-only summit that will bring together Clinical Trial Executives Representing Americas Pharmaceutical Industries and Innovative Pharmaceutical Companies from Across North America.
The summit’s content is aligned with key medical affairs challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
This year’s speaker lineup includes:
Victoria Samonte, M.D., Director, Medical Affairs, Abbott
Giovanni Passiatore, Head North America Medical Affairs, Chiesi Global Rare Diseases
Donnie Wooten, Head, Global Field Medical Excellence & Omnichannel Engagements, Organon & Co.
M…
The Ultimate Chance to Tackle Regulatory Challenges in the Cell and Gene Therapy Space!
With over 5,000 cell and gene therapies in pre-clinical and clinical development worldwide, regulatory clarity is crucial for developers striving for efficient and seamless approvals in their first regulatory submissions. Leading innovators are pioneering new approaches, like in vivo gene editing, rapidly pushing products from the clinic to commercialization. This rapidly evolving field is now on a mission to learn from case studies and glean insights from the forefront to optimize regulatory processes from pre-IND to approval.
Introducing the inaugural Cell and Gene Therapy Regulatory Affairs Summit in Washington D.C. This event will unite biopharma experts across non-clinical,clinical, and CMC regulat…
The 18th Annual Pain Therapeutics Summit serves as a catalyst for collaboration between academia, industry, and regulatory bodies, fostering a multidisciplinary exchange of ideas, expertise, and resources. Gain invaluable insights from renowned experts, network with key stakeholders, and stay at the forefront of emerging trends and breakthroughs in pain drug development.
Tickets: https://go.evvnt.com/2458285-1?pid=185
Time: 8:00 AM - 3:00 PM
Speakers: William Schmidt, Ph.D. President, NorthStar Consulting, Mary Ann Pelleymounter, Ph.D. Program Director, NINDS, Division of Translational Research, National Institutes of Health , Neil Singla, MD Chief Scientific Officer, Lotus Clinical Research , Ram Arudchandran, Ph.D. Program Director, National Institute of Neurological Disorders and Stroke…
The surge of ground-breaking updates in Geographic Atrophy, along with significant advancements in developing robust biomarkers and functional endpoints, has ignited a wave of innovation in the field of ophthalmic drug development.
The 5th Dry AMD and GA Therapeutics Summit will unite 80+ biopharma stakeholders, from discovery to early clinical development, across three days of focused discussion. This summit is the definitive forum for KOLs, industry experts, and regulators to drive the next generation of dry AMD and Geographic Atrophy therapeutics forward.
Join us to explore the latest in preclinical models, optimize trial strategies, and overcome safety and regulatory challenges to supercharge your pipeline.
URLs:Tickets: https://go.evvnt.com/2621490-2?pid=185Brochure: https://go.evvnt.…
